Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-17

Clinical Trial Update: Efficacy and Safety of Bupropion Hydrobromide in Adolescents and Children With Major Depressive Disorder [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating the efficacy and safety of bupropion hydrobromide in adolescents and children with major depressive disorder; recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupropion Hydrobromide (bupropion hydrobromide)

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Major Depressive Disorder | Phase 4 | Status: NOT_YET_RECRUITING